FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2022331577> ?p ?o ?g. }

• W2022331577 endingPage "1355" @default.
• W2022331577 startingPage "1348" @default.
• W2022331577 abstract "Pneumocystis carinii was obtained in high yield from the lungs of immunosuppressed rats by rupturing mammalian host cells, washing away the soluble mammalian dihydrofolate reductase, and harvesting intact organisms in association with the mammalian plasma membranes. P. carinii dihydrofolate reductase, measured in the 100,000 x g supernatant from sonicated organisms, was obtained in yields ranging up to 62 IU per rat. The enzyme prepared in the presence of protease inhibitors was stable when frozen in liquid nitrogen. P. carinii dihydrofolate reductase differed from the mammalian enzyme in that the former was slightly inhibited by 150 mM KCl, whereas the latter was stimulated over twofold by 150 mM KCl. The standard assay for P. carinii dihydrofolate reductase contained 0.12 mM NADPH and 92 microM dihydrofolic acid. Under these conditions, the 50% inhibitory concentrations of the known inhibitors trimethoprim, trimetrexate, and pyrimethamine were 12 microM, 42 nM, and 3.8 microM, respectively. These standard compounds were also tested against dihydrofolate reductase from rat liver to allow an assessment of the selectivity of the drugs. Although it was the least potent, trimethoprim was the most selective. Pyrimethamine was more potent but was nonselective. Trimetrexate was extremely potent but was selective for mammalian dihydrofolate reductase. A series of experimental compounds was obtained from the National Cancer Institute and other sources through the Developmental Therapeutics Branch of the Division of AIDS at the National Institute of Allergy and Infectious Diseases. Among the first 87 compounds tested, 11 had 50% inhibitory concentrations below that of trimetrexate and 3 were more selective than trimethoprim. The most promising compounds in this original group were chemically related to methotrexate." @default.
• W2022331577 created "2016-06-24" @default.
• W2022331577 creator A5001607996 @default.
• W2022331577 creator A5071627490 @default.
• W2022331577 date "1991-07-01" @default.
• W2022331577 modified "2023-10-16" @default.
• W2022331577 title "Pneumocystis carinii dihydrofolate reductase used to screen potential antipneumocystis drugs" @default.
• W2022331577 cites W1679306725 @default.
• W2022331577 cites W1958457791 @default.
• W2022331577 cites W1973136343 @default.
• W2022331577 cites W1975112632 @default.
• W2022331577 cites W1995161323 @default.
• W2022331577 cites W2012643347 @default.
• W2022331577 cites W2035936750 @default.
• W2022331577 cites W2051124537 @default.
• W2022331577 cites W2053111868 @default.
• W2022331577 cites W2086987280 @default.
• W2022331577 cites W2103116511 @default.
• W2022331577 cites W2113098684 @default.
• W2022331577 cites W2123454047 @default.
• W2022331577 cites W2158292139 @default.
• W2022331577 cites W2163041688 @default.
• W2022331577 cites W2340061261 @default.
• W2022331577 cites W2340948639 @default.
• W2022331577 doi "https://doi.org/10.1128/aac.35.7.1348" @default.
• W2022331577 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/245170" @default.
• W2022331577 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/1929292" @default.
• W2022331577 hasPublicationYear "1991" @default.
• W2022331577 type Work @default.
• W2022331577 sameAs 2022331577 @default.
• W2022331577 citedByCount "93" @default.
• W2022331577 countsByYear W20223315772014 @default.
• W2022331577 countsByYear W20223315772016 @default.
• W2022331577 countsByYear W20223315772017 @default.
• W2022331577 countsByYear W20223315772019 @default.
• W2022331577 crossrefType "journal-article" @default.
• W2022331577 hasAuthorship W2022331577A5001607996 @default.
• W2022331577 hasAuthorship W2022331577A5071627490 @default.
• W2022331577 hasBestOaLocation W20223315771 @default.
• W2022331577 hasConcept C134651460 @default.
• W2022331577 hasConcept C153911025 @default.
• W2022331577 hasConcept C159047783 @default.
• W2022331577 hasConcept C181199279 @default.
• W2022331577 hasConcept C203014093 @default.
• W2022331577 hasConcept C2776980637 @default.
• W2022331577 hasConcept C2777035104 @default.
• W2022331577 hasConcept C2777559004 @default.
• W2022331577 hasConcept C2778048844 @default.
• W2022331577 hasConcept C2778371730 @default.
• W2022331577 hasConcept C2778397455 @default.
• W2022331577 hasConcept C2780728791 @default.
• W2022331577 hasConcept C2781059491 @default.
• W2022331577 hasConcept C2781320022 @default.
• W2022331577 hasConcept C2781382166 @default.
• W2022331577 hasConcept C2993443204 @default.
• W2022331577 hasConcept C3013748606 @default.
• W2022331577 hasConcept C501593827 @default.
• W2022331577 hasConcept C55493867 @default.
• W2022331577 hasConcept C86803240 @default.
• W2022331577 hasConceptScore W2022331577C134651460 @default.
• W2022331577 hasConceptScore W2022331577C153911025 @default.
• W2022331577 hasConceptScore W2022331577C159047783 @default.
• W2022331577 hasConceptScore W2022331577C181199279 @default.
• W2022331577 hasConceptScore W2022331577C203014093 @default.
• W2022331577 hasConceptScore W2022331577C2776980637 @default.
• W2022331577 hasConceptScore W2022331577C2777035104 @default.
• W2022331577 hasConceptScore W2022331577C2777559004 @default.
• W2022331577 hasConceptScore W2022331577C2778048844 @default.
• W2022331577 hasConceptScore W2022331577C2778371730 @default.
• W2022331577 hasConceptScore W2022331577C2778397455 @default.
• W2022331577 hasConceptScore W2022331577C2780728791 @default.
• W2022331577 hasConceptScore W2022331577C2781059491 @default.
• W2022331577 hasConceptScore W2022331577C2781320022 @default.
• W2022331577 hasConceptScore W2022331577C2781382166 @default.
• W2022331577 hasConceptScore W2022331577C2993443204 @default.
• W2022331577 hasConceptScore W2022331577C3013748606 @default.
• W2022331577 hasConceptScore W2022331577C501593827 @default.
• W2022331577 hasConceptScore W2022331577C55493867 @default.
• W2022331577 hasConceptScore W2022331577C86803240 @default.
• W2022331577 hasIssue "7" @default.
• W2022331577 hasLocation W20223315771 @default.
• W2022331577 hasLocation W20223315772 @default.
• W2022331577 hasLocation W20223315773 @default.
• W2022331577 hasOpenAccess W2022331577 @default.
• W2022331577 hasPrimaryLocation W20223315771 @default.
• W2022331577 hasRelatedWork W1961044295 @default.
• W2022331577 hasRelatedWork W1966428816 @default.
• W2022331577 hasRelatedWork W1974463757 @default.
• W2022331577 hasRelatedWork W1992396816 @default.
• W2022331577 hasRelatedWork W2022331577 @default.
• W2022331577 hasRelatedWork W2038277928 @default.
• W2022331577 hasRelatedWork W2051745299 @default.
• W2022331577 hasRelatedWork W2146642815 @default.
• W2022331577 hasRelatedWork W2158292139 @default.
• W2022331577 hasRelatedWork W2402459422 @default.
• W2022331577 hasVolume "35" @default.
• W2022331577 isParatext "false" @default.
• W2022331577 isRetracted "false" @default.

• next